Beta Thalassemia Intermedia
6 clinical trials · Condition
◉ Watch Beta Thalassemia Intermedia
| Record | Firm | Date |
|---|---|---|
| The BENeFiTS Trial in Beta Thalassemia Intermedia (NCT04432623) | Phoenicia BioScience | 2020-10-05 |
| Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) (NCT04059406) | Ionis Pharmaceuticals, Inc. | 2020-09-24 |
| ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19 (NCT06831799) | Hospital Universitari Vall d'Hebron Research Institute | 2020-04-15 |
| Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. (NCT01571635) | Celgene | 2012-10-10 |
| Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon (NCT01642758) | Boston University | 2012-05-01 |
| Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand (NCT01609595) | Boston University | 2012-03-01 |
Track Beta Thalassemia Intermedia automatically
Every clearance here is in the API, with alerts when new ones post.